Literature DB >> 11208753

Synergistic Antihypertensive Effects of Nifedipine on Endothelium : Concurrent Release of NO and Scavenging of Superoxide.

Leszek Kalinowski, Reiner Muller-Peddinghaus, Tadeusz Malinski.   

Abstract

Recent studies have suggested that part of the vasorelaxation caused by nifedipine, a 1,4-dihydropyridine Ca(2+) antagonist, depends on the endothelium. To study the effect of endothelium-dependent vasorelaxation, the release of NO and superoxide (O(2)(-)) in the presence of nifedipine in isolated cultured rabbit endothelial cells was measured. Highly sensitive electrochemical microsensors were placed onto the cell membrane, and the kinetics of NO and O(2)(-) were measured simultaneously with time resolutions of 0.1 and 0.05 ms, respectively. Nifedipine at its therapeutical concentrations stimulated NO release and scavenged O(2)(-) in endothelial cells. The linear relationship between NO concentration and nifedipine concentration was observed in the range between 0.01 and 1 nmol/L. NO concentration reached a maximum of 200+/-10 nmol/L at 1.2 nmol/L of nifedipine. The NO concentration was approximately 50% and 30% of the concentration measured in the presence of receptor-dependent (acetylcholine) and the receptor-independent (Ca(2+) ionophore A23187) NO synthase (eNOS) agonists, respectively. NO release stimulated by eNOS agonists was followed by the generation of the NO scavenger superoxide. The concentration of O(2)(-) was significantly lower after stimulation with nifedipine (peak 5+/-0.5 nmol/L) than after stimulation with acetylcholine (15+/-1 nmol/L) and Ca(2+) ionophore (25+/-1 nmol/L). The average rate of NO release by nifedipine is relatively slow (17 nmol/L per second). This is in sharp contrast to the fast rate of NO release by acetylcholine and Ca(2+) ionophore (40 and 300 nmol/L per second, respectively). These experiments show that nifedipine, apart from its well-known Ca(2+) antagonistic properties in vascular smooth muscle cells, stimulates the release of significant concentration of NO in endothelium and also preserves NO concentration. Both these effects may be beneficial in the treatment of hypertension.

Entities:  

Year:  2001        PMID: 11208753     DOI: 10.1161/01.hyp.37.1.34

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

Review 2.  Advances in pharmacologic modulation of nitric oxide in hypertension.

Authors:  Yoshiko Mizuno; Robert F Jacob; R Preston Mason
Journal:  Curr Cardiol Rep       Date:  2010-11       Impact factor: 2.931

3.  Intracellular Ca2+ silences L-type Ca2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers.

Authors:  Keshari M Thakali; Sujay V Kharade; Swapnil K Sonkusare; Sung W Rhee; Joseph R Stimers; Nancy J Rusch
Journal:  Circ Res       Date:  2009-12-31       Impact factor: 17.367

4.  Calcium channel blockers increase the amount of nitrite production in rabbits without decreasing the responsiveness of platelets to collagen.

Authors:  B Sirmagül; F Ozdener; Z Gulbas; K Erol
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

Review 5.  Targeting nitric oxide with drug therapy.

Authors:  R Preston Mason; John R Cockcroft
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

Review 6.  Pleiotropic effects of calcium channel blockers.

Authors:  R Preston Mason
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

7.  Azelnidipine, Not Amlodipine, Induces Secretion of Vascular Endothelial Growth Factor From Smooth Muscle Cells and Promotes Endothelial Tube Formation.

Authors:  Akira Kawamura; Shin-Ichiro Miura; Yoshino Matsuo; Hiroyuki Tanigawa; Keijiro Saku
Journal:  Cardiol Res       Date:  2014-10-06

8.  Preconditioning with PDE1 Inhibitors and Moderate-Intensity Training Positively Affect Systemic Redox State of Rats.

Authors:  Jelena Ristic; Marko Folic; Katarina Radonjic; Milenko I Rosic; Sergey Bolevich; Omarov Israpil Alisultanovich; Nevena Draginic; Marijana Andjic; Jovana Jeremic; Isidora Milosavljevic; Vladimir Zivkovic; Vladimir Jakovljevic
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

9.  Regulation of oxidative stress and cardioprotection in diabetes mellitus.

Authors:  Tetsuya Hayashi; Tatsuhiko Mori; Chika Yamashita; Masatoshi Miyamura
Journal:  Curr Cardiol Rev       Date:  2008-11

Review 10.  Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation.

Authors:  Ramón Rodrigo; Jaime González-Montero; Camilo G Sotomayor
Journal:  Biomedicines       Date:  2021-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.